1例经皮冠状动脉介入治疗术后反复出现支架内再狭窄患者的药学监护
发布时间：2018-12-14 22:39
【摘要】：目的探讨临床药师对经皮冠状动脉介入治疗(PCI)术后患者的药学监护,为心内科临床药师开展药学服务提供参考。方法临床药师对1例PCI术后患者反复出现支架内再狭窄的因素进行分析,分别从抗血小板药物治疗的基因多态性、术后血脂和血糖的控制、用药依从性教育和出院后电话随访等方面提出建议并进行药学监护。结果与结论临床药师为临床医师对该患者药物治疗方案的调整提供了合理的建议并对其实施药学监护,半年后电话回访未出现心血管不良事件和药物不良反应,为其安全有效地用药提供保障,并提高用药依从性。
[Abstract]:Objective to explore the pharmacological monitoring of patients after percutaneous coronary intervention (PCI) by clinical pharmacists, and to provide reference for pharmacists in cardiology. Methods Clinical pharmacists analyzed the factors of recurrent restenosis in stents in one patient after PCI, and analyzed the genetic polymorphisms of antiplatelet drug therapy, the control of blood lipid and blood glucose respectively. Suggestions on drug compliance education and telephone follow-up after discharge were put forward and pharmacological monitoring was carried out. Results and conclusion Clinical pharmacists provided reasonable suggestions for clinicians to adjust the drug treatment plan of the patients and carried out pharmacological monitoring. No adverse cardiovascular events or adverse drug reactions were observed by telephone half a year later. To provide security for its safe and effective drug use, and improve drug compliance.
【作者单位】： 苏州大学附属第一医院药学部;南京医科大学附属苏州医院药学部;
【基金】：国家自然科学基金资助项目(81173132)
【分类号】：R541.4
[Abstract]:Objective to explore the pharmacological monitoring of patients after percutaneous coronary intervention (PCI) by clinical pharmacists, and to provide reference for pharmacists in cardiology. Methods Clinical pharmacists analyzed the factors of recurrent restenosis in stents in one patient after PCI, and analyzed the genetic polymorphisms of antiplatelet drug therapy, the control of blood lipid and blood glucose respectively. Suggestions on drug compliance education and telephone follow-up after discharge were put forward and pharmacological monitoring was carried out. Results and conclusion Clinical pharmacists provided reasonable suggestions for clinicians to adjust the drug treatment plan of the patients and carried out pharmacological monitoring. No adverse cardiovascular events or adverse drug reactions were observed by telephone half a year later. To provide security for its safe and effective drug use, and improve drug compliance.
【作者单位】： 苏州大学附属第一医院药学部;南京医科大学附属苏州医院药学部;
【基金】：国家自然科学基金资助项目(81173132)
【分类号】：R541.4
【相似文献】
相关期刊论文 前10条
1 张倩;朱君荣;朱余兵;;糖尿病合并高血压患者的药学监护[J];中国药师;2012年06期
2 卢浙文;;急性重症病毒性心肌炎的药学监护[J];海峡药学;2012年07期
3 吴s，
本文编号：2379440
本文链接：https://www.wllwen.com/yixuelunwen/xxg/2379440.html
最近更新
教材专著
